Skip to main content

Partners and Product Developers

The MATRIX Collaborative aims to conduct early-stage research and development of novel products for the prevention of HIV and other infectious diseases in women – particularly, women in sub-Saharan Africa.  Efficient, benchmark-driven management of the R&D portfolio is guided by the principle that all activities are grounded in North-South partnerships to enhance early R&D capacity in sub-Saharan Africa for sustainability in the region.  This ambitious and highly innovative program brings together nearly 20 partner organizations in the United States and Africa with expertise in product development, clinical trials design and implementation, social and behavioral research, stakeholder engagement and market and business case development.  At present, the MATRIX collaborative includes the following product developers and organizations:

Product Developers and US-based partners:
FHI 360
IAVI (International AIDS Vaccine Initiative) 
Magee-Womens Research Institute (MWRI)
Oak Crest Institute of Science
Population Council
Program for Appropriate Technology in Health (PATH)
Public Health Institute
RTI International
University of Alabama at Birmingham
University of Pittsburgh

African partners:
The Aurum Institute 
Centre for the AIDS Programme of Research in South Africa (CAPRISA)
Harare Health and Research Consortium
Kenya Medical Research Institute
North-West University
Pangaea Zimbabwe
University of Lagos
Wits Reproductive Health and HIV Institute (Wits RHI)